H3B-8800

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameH3B-8800
Drug Alias NameH3B-8800RVT-2001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSplicing factor 3B subunit 1 modulators
TargetsSplicing factor 3B subunit 1
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesTaiwan +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesH3 Biomedicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoivant Sciences IncHemavant Sciences GmbH
Active IndicationsN/A
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A